You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Mol. Biosci., 09 May 2025

Sec. Cellular Biochemistry

Volume 12 - 2025 | https://doi.org/10.3389/fmolb.2025.1601841

Corrigendum: Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats

  • 1. Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

  • 2. Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al Bahah, Saudi Arabia

  • 3. Chemistry Department, Faculty of Science, Taibah University, Yanbu, Saudi Arabia

  • 4. Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

  • 5. Biology Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

  • 6. Department of Pathology, Biochemistry Division, College of Medicine, Jouf University, Sakaka, Saudi Arabia

  • 7. Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

  • 8. Biochemistry Department, Science College, King Saud University, Riyadh, Saudi Arabia

  • 9. Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt

Article metrics

View details

1,1k

Views

257

Downloads

In the published article, an Author Name was incorrectly written as Norah K. Algarza. The correct spelling is Norah K. Algarzae.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

avenanthramides, antioxidants, anti-inflammatory, doxorubicin, hepatotoxicity, signaling pathway

Citation

Alwaili MA, Abu-Almakarem AS, Aljohani S, Alkhodair SA, Al-Bazi MM, Eid TM, Alamri J, Mobasher MA, Algarzae NK, A. Khayyat AI, Alshaygy LS and El-Said KS (2025) Corrigendum: Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats. Front. Mol. Biosci. 12:1601841. doi: 10.3389/fmolb.2025.1601841

Received

28 March 2025

Accepted

21 April 2025

Published

09 May 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2025

Updates

Copyright

*Correspondence: Karim Samy El-Said,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics